r.bakken
TL2 Moderator · Basel
Contributes reviews on supplier material. Based in Basel.
Joined 14 September 2025 · last posted 5d · groups: regional-na, regional-apac
82 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #58 · Access › Insurance & coverage · 23 Jul 2026 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
The report format the maintainers ask for, and why each field is there Replied, post #4 · Sourcing › Vendor reports · 17 Jul 2026 · 7 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #14 · Compounds › Tirzepatide · 14 Jul 2026 · 0 likes Picking up post #11: that is the part I would want checked first. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would…
-
What a certificate commits its issuer to Replied, post #14 · Analytics › COA interpretation · 11 Jul 2026 · 0 likes On post #10 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #49 · Clinical › Comorbidities · 3 Jul 2026 · 3 likes On post #45 — agreed on the reasoning, with one qualification. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people…
-
Pages past their review date, listed — does this still hold? Replied, post #35 · Meta › Wiki maintenance · 3 Jul 2026 · 2 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #3 · Practice › Administration · 30 Jun 2026 · 11 likes I read the opening post twice before replying, because I had assumed the opposite. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue…
-
Coming back to: A structured critique template this community uses Replied, post #44 · Evidence › Study critique · 27 Jun 2026 · 15 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
What a certificate commits its issuer to — the long version Replied, post #17 · Analytics › COA interpretation · 23 Jun 2026 · 2 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #9 · Analytics › Impurities & related substances · 18 Jun 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #81 · Evidence › Preprints · 17 Jun 2026 · 13 likes post #80 answers the question as asked. The question underneath it is different. Discussing preprints in this community: bring them in for early discussion, label them…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #27 · Compounds › Tirzepatide · 10 Jun 2026 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance…
-
Transporting a vial for a weekend away — a second dataset Replied, post #48 · Practice › Storage & stability · 9 May 2026 · 0 likes post #47 is right about the mechanism and I think understates the practical bit. Protecting from light: amber vials or opaque containers reduce light exposure. If you…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #6 · Analytics › HPLC & UHPLC · 7 May 2026 · 11 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Request: show the solution author in the topic list — what changed since Replied, post #32 · Meta › Feature requests · 1 May 2026 · 11 likes Worth separating two things that post #28 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Spike-and-recover accuracy for a peptide assay Replied, post #46 · Analytics › Method validation · 8 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #32 · Compounds › Semaglutide · 7 Apr 2026 · 17 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Dizziness on standing: the ordinary explanation first — one year on Started this topic · Nutrition & Training › Hydration & electrolytes · 7 Apr 2026 · 4 likes Dizziness on standing: the ordinary explanation first — one year on — setting out what I have, and where I think it stops being reliable. Longitudinal report with the…
-
[2026 update] What a purity-only report leaves out Replied, post #66 · Sourcing › Independent verification · 25 Mar 2026 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #71 · Practice › Interactions · 20 Mar 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Second pass at: Fasting versus non-fasting and which tests care Replied, post #20 · Clinical › Bloodwork · 19 Mar 2026 · 3 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #35 · Practice › Interactions · 11 Mar 2026 · 11 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Cost per delivered dose, which is the number that matters Replied, post #55 · Access › Pricing · 8 Mar 2026 · 12 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #50 · Sourcing › Logistics · 6 Mar 2026 · 5 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #16 · Research Methods › N-of-1 designs · 26 Feb 2026 · 0 likes post #15 is right about the mechanism and I think understates the practical bit. Generalisability: a robust n-of-1 result applies to you. It does not tell you much…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #109 · Clinical › Special populations · 24 Feb 2026 · 5 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #50 · Compounds › Tirzepatide · 24 Feb 2026 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #9 · Sourcing › Red flags · 23 Feb 2026 · 1 like I read post #7 twice before replying, because I had assumed the opposite. Pricing patterns: unusually low prices for what are otherwise consistent with market rates…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #117 · Analytics › Mass spectrometry · 16 Feb 2026 · 0 likes Worth separating two things that post #113 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Run-in periods and the population they select Replied, post #63 · Evidence › Trials · 8 Feb 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
How to ask about something you suspect is a bad idea Replied, post #52 · Start Here › How to Ask · 6 Feb 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #23 · Regional › UK & Ireland · 28 Jan 2026 · 0 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Lyophilisation and why the cake looks the way it does Replied, post #33 · Pharmacology › Formulation chemistry · 6 Jan 2026 · 1 like I read post #31 twice before replying, because I had assumed the opposite. Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol,…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #32 · Sourcing › Vendor reports · 3 Jan 2026 · 0 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #16 · Sourcing › Red flags · 15 Dec 2025 · 10 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Robustness: the parameters worth deliberately varying Replied, post #58 · Analytics › Method validation · 11 Dec 2025 · 2 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Liver enzymes drifting down and what that usually means Replied, post #35 · Clinical › Bloodwork · 10 Dec 2025 · 31 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
What I would record differently if I started again — the long version Replied, post #16 · Outcomes › Progress reports · 12 Nov 2025 · 0 likes On post #12 — agreed on the reasoning, with one qualification. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg"…
-
Specification in the result column: why that is a meaningful error Replied, post #68 · Analytics › COA interpretation · 4 Nov 2025 · 5 likes Worth separating two things that post #64 runs together. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not…
-
Revisiting: German, French and Dutch differences, compared Replied, post #95 · Regional › European Union · 1 Nov 2025 · 30 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
-
Amylin receptor signalling and satiety Replied, post #8 · Pharmacology › Receptor biology · 23 Oct 2025 · 11 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #79 · Practice › Storage & stability · 11 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #86 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 18 likes post #85 is right about the mechanism and I think understates the practical bit. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted…
-
Temperature loggers worth the money — the long version Replied, post #40 · Devices › Cold chain · 14 Sep 2025 · 1 like This follows post #37 rather than contradicting it. Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #79 · Practice › Side effects · 8 Sep 2025 · 0 likes Picking up post #76: that is the part I would want checked first. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some…
-
What this community means by "a source", in practical terms Replied, post #36 · Start Here › Welcome · 16 Jul 2025 · 3 likes This follows post #33 rather than contradicting it. The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #25 · Compounds › Secretagogues & GH axis · 15 Jul 2025 · 7 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
A field-by-field walk through a certificate of analysis Replied, post #18 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes post #17 is right about the mechanism and I think understates the practical bit. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
Titles that describe the question, not the situation Replied, post #40 · Start Here › How to Ask · 2 Jul 2025 · 0 likes On post #36 — agreed on the reasoning, with one qualification. Context that matters: compound, how long in, current dose, relevant history. Context that does not…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #68 · Sourcing › Independent verification · 22 Jun 2025 · 0 likes post #67 is right about the mechanism and I think understates the practical bit. Cost and turnaround: different services have different pricing and turnaround times.…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #120 · Access › Insurance & coverage · 15 Jun 2025 · 14 likes Coming back to post #118, because the follow-up matters more than the original answer. Coverage for weight management versus diabetes: many formularies cover these…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #74 · Outcomes › Body composition · 21 May 2025 · 28 likes post #73 is right about the mechanism and I think understates the practical bit. Changes during titration: measuring body composition during active titration is less…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #82 · Practice › Interactions · 12 May 2025 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
The C-cell question: rodent findings and their human context Replied, post #12 · Compounds › Semaglutide · 30 Apr 2025 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Follow-up: Documentation that appears only after payment Replied, post #15 · Sourcing › Red flags · 22 Apr 2025 · 8 likes Coming back to post #13, because the follow-up matters more than the original answer. Exaggerated claims without documentation: every compound has limits. No peptide is…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #23 · Clinical › Comorbidities · 20 Apr 2025 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Follow-up: Requesting a page: what makes a good request Replied, post #21 · Documentation › Wiki requests · 13 Apr 2025 · 28 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #56 · Compounds › Tirzepatide · 7 Apr 2025 · 23 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Foaming during reconstitution and whether it matters Replied, post #7 · Practice › Reconstitution · 22 Mar 2025 · 25 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #7 · Compounds › Retatrutide · 21 Mar 2025 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #20 · Compounds › Repair & healing peptides · 4 Mar 2025 · 30 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #19 · Compounds › Tirzepatide · 28 Feb 2025 · 8 likes This follows post #16 rather than contradicting it. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure,…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #13 · Meta › Wiki maintenance · 26 Feb 2025 · 0 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #13 · Clinical › Comorbidities · 12 Feb 2025 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. Interactions between comorbidities: diabetes and kidney disease together change the risk…
-
Validating a method you did not develop — does this still hold? Replied, post #4 · marked as the solution · Analytics › Method validation · 12 Feb 2025 · 9 likes This follows the opening post rather than contradicting it. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #51 · Analytics › Mass spectrometry · 9 Feb 2025 · 24 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
When "no data" is the complete and final answer Replied, post #81 · Compounds › Other compounds · 1 Feb 2025 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #95 · Compounds › Oral incretins · 28 Dec 2024 · 31 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Ipamorelin selectivity claims and where they came from Replied, post #3 · Compounds › Secretagogues & GH axis · 27 Dec 2024 · 8 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #119 · Analytics › COA interpretation · 16 Nov 2024 · 26 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Time to steady state after a dose increase Replied, post #73 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 27 likes On post #69 — agreed on the reasoning, with one qualification. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #57 · Devices › Syringes & needles · 29 Oct 2024 · 2 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #110 · Clinical › Comorbidities · 27 Oct 2024 · 0 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #6 · Evidence › Journal club · 9 Oct 2024 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Progressive overload when the scale is falling — one year on Replied, post #40 · Nutrition & Training › Resistance training · 9 Sep 2024 · 7 likes Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #36 · Sourcing › Independent verification · 4 Sep 2024 · 23 likes post #35 answers the question as asked. The question underneath it is different. Interpreting a result: a purity figure is one measurement on one vial on one day.…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #6 · Practice › Administration · 2 Sep 2024 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #22 · Evidence › Journal club · 21 Aug 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #65 · Compounds › Retatrutide · 20 Jul 2024 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #18 · Safety › Contraindications · 20 Jul 2024 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Cold packs, phase-change material, and what survives ten days Replied, post #54 · Sourcing › Logistics · 29 Jun 2024 · 3 likes Worth separating two things that post #50 runs together. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not…
-
Assessing a warm arrival: the decision process — one year on Replied, post #119 · Sourcing › Logistics · 2 Jun 2024 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…